ADARx Pharmaceuticals, Inc. (ADRX) vs Arxis, Inc. Class A Common Stock (ARXS)

A side-by-side comparison of ADARx Pharmaceuticals, Inc. and Arxis, Inc. Class A Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADRX

ADARx Pharmaceuticals, Inc.

$1.90B

$18.63IndustrialsDelayed quote: Oct 6, 2026, 11:34 AM EDT

ARXS

Arxis, Inc. Class A Common Stock

$2.02B

$49.87IndustrialsDelayed quote: Oct 6, 2026, 11:35 AM EDT

Total return — ADRX vs ARXS

growth of $100 · dividends reinvested · last 1y

ADRX -1.6% (-1.6%/yr)ARXS +0.0% (+0.0%/yr)ARXS compounded faster over this window

ADRX ARXS

Metrics side by side

ADRX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ADRX analysis Full ARXS analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.